The Growth Strategy Series: A Chemist's Journey from Academia to a Startup

Following the introduction of Yinqi and her expertise in biocatalysis, we now turn to synthetic organic chemist, Becky

Becky’s decision to join HydRegen was motivated by her interest in being part of a startup’s dynamic and fast-paced environment. Attracted by the potential to take on diverse responsibilities to broaden her skill set and gain experience, she was also excited by the opportunity to witness and contribute to the company's growth. A decision that prompted her move from academia in the United States to the UK. 

Bridging Chemistry and Biotechnology 

As a synthetic organic chemist, Becky brings a critical perspective to HydRegen. Helping to translate and communicate complex biocatalytic technology to chemists who may have little to no experience in biocatalysis. This interdisciplinary approach provides the framework to bridge gaps between different disciplines, helping to accelerate innovation and problem-solving. A strategy that results in faster product development, market readiness and business growth. 

Becky’s expertise in synthetic organic chemistry is invaluable in addressing the unique challenges posed by biocatalysis. Her ability to approach problems from a chemist’s point of view, while collaborating with biologists and bio-engineers, enriches the interdisciplinary efforts that are key to HydRegen’s success. 

Becky’s expertise in synthetic organic chemistry is invaluable in addressing the unique challenges posed by biocatalysis. Her ability to approach problems from a chemist’s point of view, while collaborating with biologists and bio-engineers, enriches the interdisciplinary efforts that are key to HydRegen’s success. 

" Biocatalysis presents unique challenges compared to other methods, so I leverage my organic chemistry background to offer a fresh perspective on these issues." 

Transitioning from Academia to Industry: Insights and Benefits 

For those considering a move from academia to a startup, Becky confirms that while the workflow in both environments is collaborative and goal-oriented, the nature of the goals often differs. In academia, the focus is often on intellectual exploration and curiosity, while in a startup, the objectives are more practical, and customer-driven.  

Life at a startup can be advantageous however, offering a much-improved work-life balance. In academia, long hours and intense focus on research can make it challenging to maintain a healthy balance between work and personal life but at HydRegen, Becky has found that achieving this balance not only enhances her well-being but also positively impacts the quality of her work. 

Since joining HydRegen, the company’s smaller size which helps foster a strong sense of camaraderie and collaboration, has supporting Becky in adjusting to life in a new country. The international diversity within the team, many of whom are also from different parts of the world not only eased Becky’s transition but provided her with new perspectives that enhance the collaborative environment at HydRegen.  

 Continuous Development and Growth 

HydRegen’s commitment to the personal and professional development of its team members has been evident in Becky’s experience. Since joining the company, she has participated in various training programs that support her growth both within the lab and in developing interpersonal skills. Additionally, the opportunity to attend conferences has allowed her to stay up to date with the latest advancements in her field, further enriching her contributions to the company. 

The Impact of Diverse Expertise at HydRegen 

Becky’s journey at HydRegen highlights the value of bringing diverse expertise into the fold of a biotechnology startup. Her background in synthetic organic chemistry provides a crucial link between traditional chemistry and the innovative biocatalysis work being done whilst her international experience and collaborative spirit further enhance the team’s ability to tackle complex challenges and drive the company forward. 

 

Previous
Previous

How we work with Pharma

Next
Next

Investing in Green Chemistry: Why BioTech is a Big Opportunity